Sleep Medicine Board Review: Sleep-Wake Regulation Explained

Added:

Glia-Centric and Local Sleep Regulation

Traditional sleep-wake regulation models taught for board exams, such as the 'flip-flop switch' and the Two-Process Model, focus heavily on centralized, neuron-driven pathways and systemic neurotransmitters. However, an increasingly prominent alternative perspective challenges this top-down, neuron-centric view by proposing that sleep is a decentralized, 'local' phenomenon. Proponents of 'local sleep' argue that individual cortical columns can enter sleep-like states independently based on prior local metabolic activity, regardless of overall organism wakefulness. Furthermore, emerging research highlights the critical role of non-neuronal cells, particularly astrocytes (glial cells), in regulating adenosine accumulation and driving sleep homeostat (Process S). By focusing on glia-centric mechanisms and localized cellular metabolism rather than just centralized neuronal circuits, this paradigm shifts the understanding of sleep-wake regulation from a centralized master switch to a bottom-up, cellularly distributed process.

Basic neuroanatomy of the brainstem, hypothalamus, and thalamus, specifically focusing on the ascending reticular activating system (ARAS).
Fundamental principles of neurochemistry, including the classical excitatory and inhibitory neurotransmitters (e.g., GABA, glutamate, acetylcholine, and monoamines).
The Two-Process Model of Sleep Regulation, explaining the interplay between homoeostatic sleep pressure (Process S) and the circadian drive (Process C).
The basic stages of human sleep architecture, including the physiological distinctions between Non-REM (N1, N2, N3) and REM sleep.
The pathophysiology, clinical presentation, and diagnostic criteria for central disorders of hypersomnolence, such as Narcolepsy Type 1 and Type 2.
Pharmacotherapy in sleep medicine, focusing on the mechanisms of action of wake-promoting agents, orexin receptor antagonists, and sedative-hypnotics.
Clinical evaluation and management strategies for Circadian Rhythm Sleep-Wake Disorders (CRSWDs), including the therapeutic use of actigraphy, light therapy, and exogenous melatonin.
Advanced interpretation of diagnostic sleep studies, including Polysomnography (PSG) and the Multiple Sleep Latency Test (MSLT) for board level certification.
161 views2likes16:18@BoardPrepbyThePassMachineOriginal Release: 2024-12-10

Sleep-wake control is regulated by two competing processes: Process S (sleep pressure/homeostatic drive) that builds as waste products like adenosine accumulate during wakefulness, and Process C (circadian alerting signal) generated by blue light exposure through melanopsin-producing retinal ganglion cells that feed back to the suprachiasmatic nuclei to inhibit melatonin production; the balance between these processes, along with orexin/hypocretin's role in inhibiting GABA production in the ventrolateral preoptic nucleus and activating wake-promoting neurotransmitters, determines the transition between sleep and wake states, with core body temperature minimum and dim light melatonin onset serving as key circadian markers for sleep timing.